Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Schouw & Co unit BioMar lifts 2026 outlook, sees revenue DKK 17-18 billion, EBIT DKK 1.2-1.3 billion

Schouw & Co unit BioMar lifts 2026 outlook, sees revenue DKK 17-18 billion, EBIT DKK 1.2-1.3 billion

ReutersReuters2026/08/12 11:35
  • Schouw flagged an update to its 2026 outlook following a guidance raise at fully consolidated unit BioMar.
  • BioMar now targets revenue of DKK 17-18 billion, up from DKK 16-17 billion.
  • BioMar lifted expected EBIT to DKK 1.2-1.3 billion from DKK 1.1-1.2 billion.
  • Schouw guides on revenue, EBITDA; consolidated 2026 guidance review due by the Aug. 14 interim report.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Schouw & Co. A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608120733OMX_____CNEWS_EN_GNW1001257253_en) on August 12, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

With support from Ober and Bain Capital, RNA rising star Adarx submits US IPO application

Adarx Pharmaceuticals Inc. has filed for an IPO in the United States to help fund the development of a pipeline of drugs aimed at treating various diseases by regulating gene expression.

智通财经2026/09/05 01:16
With support from Ober and Bain Capital, RNA rising star Adarx submits US IPO application